Medtronic plc announced that the US Food and Drug Administration (FDA) has approved its Percept? RC Deep Brain Stimulation (DBS) System. Is the rechargeable neurostimulator Percept’s latest innovation?
family, why also the Percept? Neurostimulator for PC, BrainSense?? technology+ and SenSight?
directional distractions. The Percept?? family is the only sensor-based DBS system on the market, allowing the clinician to personalize the treatment of patients with movement disorders such as Parkinson’s disease, essential tremor, dystonia* and epilepsy.
More than 11 million people in the United States live with movement disorders1-2 and approximately 3.4 million with epilepsy3. DBS uses a surgically implanted medical device, similar to a pacemaker. Medtronic Percept?®?
Neurostimulators send electrical signals through thin wires to specific brain targets affected by debilitating neurological conditions such as Parkinson’s disease. Perception? RC is the smallest and thinnest dual-channel++ neurostimulator available for DBS.
Does it have BrainSense? technology that captures and records brain signals to provide insights that allow a healthcare provider to adapt and personalize therapy to the patient’s changing needs. Unlike other rechargeable devices, the Percept?
The RC battery has a lifespan of at least 15 years with constant and fast charging performance. Medtronic’s patented battery technology reduces battery consumption compared to other rechargeable devices, resulting in a more reliable, long-lasting battery. SS patients can be rapidly charged from 10% to 90% full charge in less than an hour. It is estimated that nearly 70% of all patients eligible for DBS require an MRI as part of their essential care4.
Medtronic was the first in the United States to offer conditional whole-body MRI systems that allow patients to obtain safe scans anywhere on the body under specific conditions++. Perception?? offers greater scanning freedom and access for patients with 3T scans and best-in-class labeling of 1.5T MRI scans5-7. Furthermore, the Percept?
neurostimulators designed so that future software updates designed for Percept?? platform are possible without having to replace the neurostimulator device.
2024-01-08 17:38:00
#Medtronic #plc #announces #FDA #approval #Percept #Deep #Brain #Stimulation #System #January